Kaplan-Meier survival curves for ROR1+ and ROR1-negative pediatric B-ALL patients revealed no difference regardless of whether (p = 0.334) or whether not (p = 0.452) the E2A-PBX1 group was included. The gene discussed is PBX1; the disease is precursor B-cell acute lymphoblastic leukemia.